What is it about?
Whether Neurofilament contributes to a panel of CSF biomarkers to discriminate between PD patients and controls.
Featured Image
Why is it important?
We are still searching for a biomarker panel with high sensitivity and specificity. NFL could contribute to this panel and shown in this paper.
Read the Original
This page is a summary of: CSF or serum neurofilament light added to α‐Synuclein panel discriminates Parkinson's from controls, Movement Disorders, November 2019, Wiley,
DOI: 10.1002/mds.27897.
You can read the full text:
Contributors
The following have contributed to this page
